Seagen Debuts In EU With Tukysa Launch & Sees UK As 'Key' Future Market

Pricing And Reimbursement Talks Getting Under Way

 
• By Ian Schofield
  
UK and EU flags
Seagen plans to market its breast cancer drug in the EU and the UK • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography